10:17 AM EDT, 05/08/2025 (MT Newswires) -- Edgewise Therapeutics ( EWTX ) shares were down more than 3% early Thursday after the company reported a Q1 net loss of $0.43 per diluted share, widening from $0.42 the preceding quarter.

Analysts polled by FactSet expected a GAAP loss of $0.43 per share.

No revenue was reported for the quarter ended March 31.

Price: 14.06, Change: -0.46, Percent Change: -3.17